Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1377173 | Bioorganic & Medicinal Chemistry Letters | 2007 | 5 Pages |
A new series of non-peptidic, mono-acid protein tyrosine phosphatase 1B (PTP1B) inhibitors has been identified by structure-based design. Compounds with 2-(indol-3-yl)- and 2-phenyl-3,3,3-trifluoro-2-hydroxypropionic acid core units targeted at the enzyme’s primary site and a hydrophobic chlorophenylthiazole extension in its 2° site exhibit 3–60 μM IC50s for PTP1B inhibition in an Sf9 cell-based assay.
Graphical abstractA new series of protein tyrosine phosphatase 1B inhibitors with a 2-aryl-3,3,3-trifluoro-2-hydroxypropionic acid core unit targeted at the enzyme’s primary site and a hydrophobic chlorophenylthiazole extension in the 2° site exhibit low-μM inhibitory activity in cell-based assays.Figure optionsDownload full-size imageDownload as PowerPoint slide